FDA Inspection
VRL EurofinsVRL Eurofins – FDA Inspection, Oct 29, 2014
Record Details
This FDA Inspection record concerns VRL Eurofins, with an inspection on October 29, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- VRL Eurofins
- Inspection Date
- October 29, 2014
- Product Type
- Biologics
View Company Profile
ID · df00af64-ef74-466d-a350-c3c328eeb075
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 901718
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.210(d)(3)Lot documentation maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of VRL Eurofins
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 26, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 14, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for VRL Eurofins
- FDA Inspection 1261192 - 2025-01-30
- FDA Inspection 1130375 - 2020-08-26
- FDA Inspection 1027461 - 2017-09-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.